A review of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation

Clinical Therapeutics

Volumn 23, Issue 10, 2001, Pages 1628-1636

  Abdelhafiz, Ahmed H ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Anticoagulation; Atrial fibrillation; Clinical practice; Efficacy; Safety

Indexed keywords

WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; CAREGIVER; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COST; DRUG EFFICACY; DRUG SAFETY; HEART ATRIUM FIBRILLATION; HUMAN; MEDICAL INFORMATION; PATIENT SELECTION; PROPHYLAXIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; STROKE;

EID: 0035159916     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80134-X     Document Type: Article

References (40)

1. Atrial fibrillation: A major contributor to stroke in the elderly. The Framingham Study
2. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
3. Antithrombotic therapy in atrial fibrillation
4. Medical treatment for stroke prevention
5. Preventing stroke in patients with atrial fibrillation
6. Service provision and use of anticoagulants in atrial fibrillation
7. Stroke Prevention in Atrial Fibrillation Study. Final results
8. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation
9. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study
10. Canadian Atrial Fibrillation Anticoagulation (CAFA) study
11. The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The BAATAF study
12. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
13. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
14. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study
15. Stroke and atrial fibrillation: Is stroke prevention treatment appropriate beforehand?
16. Treatment of atrial fibrillation in a district general hospital
17. A survey of acute admissions with atrial fibrillation in a multiracial hospital population
18. Survey of use of anticoagulation in patients with atrial fibrillation
19. Oral anticoagulation in patients with atrial fibrillation: Adherence with guidelines in an elderly cohort
20. Temporal trends in the use of anticoagulants among older adults with atrial fibrillation
21. Warfarin for stroke prevention still underused in atrial fibrillation: Patterns of omission
22. Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
23. Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?
24. Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: Randomised controlled trial comparing two intensities of coumarin with aspirin
25. Can warfarin randomized trials be reproduced in 'real life'? Adherence to warfarin guidelines for intensity of anticoagulation in a university-based warfarin clinic
26. Consensus guidelines for coordinated outpatient oral anticoagulation therapy management
27. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range
28. Quality of anticoagulation management among patients with atrial fibrillation: Results of a review of medical records from 2 communities
29. Do anticoagulation clinics treat patients more effectively than physicians?
30. A structured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial
31. Complication rates for a telephone-based anticoagulation service
32. Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes, and health care costs
33. Long-term patient self-management of oral anticoagulation
34. Anticoagulant prophylaxis against stroke in atrial fibrillation: Effectiveness in actual practice
35. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness
36. Risk factors for intracranial hemorrhage in outpatients taking warfarin
37. Incidence of new thromboembolic stroke in persons 62 years and older with chronic atrial fibrillation treated with warfarin versus aspirin
38. Oral anticoagulation treatment in the elderly: A nested, prospective, case-control study
39. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation
40. Risk assessment and anticoagulation for primary stroke prevention in atrial fibrillation